Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156908 · ClinicalTrials.gov registry record · Phase 2
D-serine and Cognitive Remediation in Schizophrenia
A Phase 2 study, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT02156908 is a Phase 2 study that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 8 participants.
The verdict
NCT02156908, a Phase 2 study, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The investigators will test the effects of 3 days of D-serine (DSR) on auditory plasticity in a sensory based remediation (SBR) paradigm
Interventions
- DRUG D-serine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02156908
The ClinicalTrials.gov registry entry for NCT02156908 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-serine is the first listed.
NCT02156908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02156908 about?
NCT02156908 is a clinical study titled "D-serine and Cognitive Remediation in Schizophrenia". The investigators will test the effects of 3 days of D-serine (DSR) on auditory plasticity in a sensory based remediation (SBR) paradigm
What is the current status of trial NCT02156908?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2014-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02156908?
The interventions under investigation include: D-serine (DRUG).
Who is sponsoring clinical trial NCT02156908?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.